Overview

Capecitabine in Metastatic Breast and GI Cancers

Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is compare different doses of capecitabine to see if one is better than the other in terms of efficacy and toxicity.
Phase:
Phase 2
Details
Lead Sponsor:
Qamar Khan
University of Kansas Medical Center
Treatments:
Capecitabine